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During differentiation stem cells are exposed to a range of microenvironmental chemical and 
physical cues. In this study, human multipotent progenitor cells (hMLPCs) were differentiated 
from umbilical cord into oligodendrocytes and astrocytes. Chemical cues were represented by a 
novel defined differentiation medium containing the neurotransmitter norepinephrine (NE). In 
traditional 2 dimensional (2D) conditions, the hMLPCs differentiated into oligodendrocyte 
precursors, but did not progress further. However, in a constructed 3 dimensional (3D) 
environment, the hMLPCs differentiated into committed oligodendrocytes that expressed MBP.  
When co-cultured with rat embryonic hippocampal neurons (EHNs), hMLPCs developed in 
astrocytes or oligodendrocytes, based on presence of growth factors in the differentiation 
medium. In co-culture, physical cues provided by axons were essential for complete 
differentiation of both astrocytes and oligodendrocytes. This study presents a novel method of 
obtaining glia from human MLPCs that could eliminate many of the difficulties associated with 
their differentiation from embryonic stem cells. In addition, it reveals the complex interplay 
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1. INTRODUCTION AND REVIEW OF THE LITERATURE 
1.1. Oligodendrocytes: Historical Overview 
Oligodendrocytes are glial cells in central nervous system (CNS).  They were the last glial cells 
discovered at the beginning of the 20th century. These cells were resistant to classical metal 
impregnations used for staining cells. However, a new staining method created by Pio del Rio 
Hortega led him to visualize these cells in 1921. He introduced the word "oligodendrocyte" from 
the Greek -oligo- for few, -dendro- for tree, and -cyte- for cell, to describe a cell with fewer 
processes than the other cells. Oligodendrocytes make and maintain CNS myelin, the protective 
sheath around axons, referred to as white matter
1
.  The myelin sheath is a lipid rich membrane 
formed by modified extensions of oligodendroglial cell processes, wrapped in a spiral fashion 
around an axon
2
. The word myelin originates from Greek myelos, meaning marrow.  Myelin was 
named and described in 1858 by the German pathologist Rudolf Virchow because of its 
resemblance to marrow, long before its function or its composition was known. Each 




.  The sections of myelin are 
separated from each
 
other by small segments in which the bare axon is exposed to
 
the interstitial 
space. These segments are called nodes of Ranvier,
 
after the French histologist Louis-Antoine 
Ranvier who described them for the first time in 1878. Nodes of Ranvier are the location of 
multiple sodium channels. Along unmyelinated fibers, action potential moves continuously.  
However, when the axon is myelinated, the electrical impulse cannot
 
flow through the high-
resistance myelin sheath and therefore
 
flows out through from one node of Ranvier to the next 
2 
 
node with little energy and increased
 
speed. The non-linear and rapid conduction of electrical 





Figure 1. Oligodendrocytes.  
Fluorescent light micrograph of oligodendrocytes from a mouse. The mouse had been genetically 
engineered to express green fluorescent protein (GFP) in its oligodendrocytes. 
 
Figure 2. Electron Micrograph Image. Branched Oligodendrocytes with Processes Extending to 
Underlying Axons (http://www.regenecell.com). 
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1.2. Astrocytes: Rising Stars  
 
Astrocytes are star-shaped glial cells. They are the most numerous cell type within the central 
nervous system (CNS), first identified at the 19
th
 century by Von Lenhossek
6
.  Until recently, 
astrocytes have been considered to be uninteresting „brain glue‟, providing an inert scaffold and 
nutritional support necessary for neuronal distribution and interactions
7
. Recent findings suggest 
many new functions for these cells and highlight the importance of viewing most brain activities 
as collaboration between astrocytes and neurons. Astrocytes have been implicated in 
maintenance of the blood-brain barrier, dynamic regulation of neuron production, synaptic 
network formation and neuron electrical activity and in specific neurological diseases. This 
multi-functionality may explain the multiplicity of astrocyte subtypes found throughout the CNS. 
The human CNS has the highest numbers of glia, the greatest glia-neuron ratio
8-10
, and the 
greatest heterogeneity of glial cells
11
 compared with other animal species. The broad category of 
astrocytes is subdivided into fibrous or protoplasmic subtypes, based on their morphology, 
antigen binding and localization to white or gray matter
12
. Fibrous astrocytes have many glial 
filaments and are located mainly in white matter; protoplasmic astrocytes have fewer glial 
filaments and are found mainly in gray matter
12, 13
. Whereas fibrous astrocytes tend to have 
regular contours and to extend cylindrical branching processes, protoplasmic astrocytes have 
irregular contours and extend sheet-like processes. Fibrous and protoplasmic astrocytes were 
suggested to be biochemically and developmentally distinct and correspond to the type-1 and 










Figure 3. Glia-neuron interaction.  
Different types of glia interact with neurons and the surrounding blood vessels. 
Oligodendrocytes wrap myelin around axons to speed up neuronal transmission. Astrocytes 
extend processes that ensheath blood vessels and synapses. Microglia keep the brain under 







1.3. Development of Oligodendrocytes and Astrocytes 
Oligodendrocytes and astrocytes arise from neuroepithelial stem cells early during development 
of brain and spinal cord. Neuroepithelial stem cells proliferate and give rise first to motoneuron 
and later to glial progenitor cells
16-19
.  Some findings provide evidence that a common glial 
progenitor cell gives rise to both oligodendrocytes and astrocytes
20-22
. Other findings suggest that 
oligodendrocytes either derive independently or derive from common motoneuron and 
oligodendrocyte precursors
23, 24
. The most recent studies support a sequential model of 
differentiation (Figure3). In this model, motoneurons, oligodendrocytes and astrocytes arise 





Figure 4. Sequential Model.  
The sequential model explains how neuroepithelial stem cells (NSC) might generate 
motoneurons (MN), oligodendrocytes (O) and astrocytes (Ast) (pM, motoneuron precursor; 
OPC, oligodendroctye precursor; pA, astrocyte precursor). NSCs at different stages in the 





The precursors are found in close contact with the surrounding environment that serves as a 
source of many chemical and biophysical signals. The signals from other cells and the 
extracellular environment are then integrated with the intracellular forces to control proper and 
timely differentiation
26
. The early steps of differentiation can sometimes be reversed or altered 
when specific microenvironmental signals are absent or overridden
27
. For example, bi-potential 
glial progenitor cells were shown to develop in vitro into a specific astrocyte population (the 
type-2
 
astrocyte) if cultured in presence of serum or into oligodendrocytes if cultured in the 
absence of serum
28
. In certain culture conditions some of these cells acquire a mixed phenotype, 
displaying properties of both astrocytes and oligodendrocytes, or revert back to stem cell like 
cells. Due to its potential, the single glial progenitor cell is alternatively called an 
oligodendrocyte type-2 astrocyte
 
(O2A) progenitor or an oligodendrocyte precursor cell (OPC)
29
. 
O2As can be immunostained with the monoclonal antibody A2B5, which detects gangliosides on 
the surface of the cells
30
. 
The progression of the oligodendroglial linage is characterized by dramatic morphological 
changes and the acquisition of specific surface antigens.  The oligodendrocyte progenitors can be 
detected with the A2B5 antibody. Precursors express the O4 sulfatide, which persists in ramified 
but yet immature oligodendrocytes. Committed oligodendrocytes lose A2B5 reactivity after they 
begin to express O1 galactocerebroside.  Differentiated oligodendrocytes, which are post-mitotic 
and richly multipolar cells, when mature, express myelin proteins such as myelin basic protein 
(MBP), and gradually initiate the process of myelination
30-33
.  
Developing type-2 astrocytes exhibit radial processes and also express the gangliosides detected 
with the A2B5 antibody at early stages of differentiation. However, they are distinguished from 
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O2As by their expression of the astrocyte marker, glial fibrillary acidic protein (GFAP). As 
astrocytes mature, their GFAP expression remains, while A2B5 immunoreactivity diminishes. 
The type-2 astrocytes can be found in white but mainly in gray matter throughout the CNS
12, 14
.  
They were observed in tracts of myelinated axons and there is evidence that processes from type-
2 astrocytes contribute to the structure of nodes of Ranvier. They have been also shown to 
promote myelination in response to electrical impulses
34
. It has been suggested that the O2A 













Figure 5. Diagram Depicting the Differentiation of the O2A Lineage.  
The differentiation of oligodendrocytes from their progenitors follows a morphological 
transformation from a GD3 positive spherical stem cell to the A2B5 and nestin positive 
bipotential O2A precursor cell. When cultured in the presence of defined medium, the O2A 
precursors becomes a prooligodendrocyte, which is multipolar, has short processes, and exhibits 
immunoreactivity with the O4 antibody. The prooligodendrocyte differentiates into the 
galactocerebroside (GC or O1 antigen) positive oligodendrocyte.  When the O2A precursor is 
cultured in the presence of serum, it differentiates into the A2B51 type 2 astrocyte, expressing 






1.4. Effect of Noradrenergic Signaling on Oligodendrocyte and Astrocyte Differentiation 
Differentiation of oligodendrocytes and astrocytes in the local tissue environment depends 
closely on the gradients of soluble factors and physical cues activating distinct signaling 
pathways. The development to an oligodendrocytes phenotype is controlled by distinct molecular 
mechanisms. The soluble factors involve platelet-derived growth factor-AA (PDGF-AA), basic 
fibroblast growth factor (bFGF), epidermal growth factor (EGF) and changes in intracellular 
cyclic adenosine monophosphate (cAMP) levels. Another soluble factor involved in 
differentiation is norepinephrine (NE)
36-39
. NE is a small molecule catecholamine with a dual 
role as a hormone and a neurotransmitter.  As a hormone, it is secreted by the adrenal gland and 
along with epinephrine it affects the fight or flight response during times of stress.  As a 
neurotransmitter it is released from noradrenergic neurons and modulates emotions, learning and 
memory
40-42
. NE has been shown to be involved in the development and functional maturation of 
spinal cord
43
. The noradrenergic nerve terminals can be visualized in the ventral horn at birth, 
with a pattern similar to that of the adult, and regulate development of spinal motoneurons
43-45
.  
Previous studies demonstrated a function of NE in the neuronal differentiation of cells that 
express adrenergic receptors (ARs)
46, 47
.  The effect of NE on oligodendrocyte differentiation is 
not well understood. However, it was revealed that noradrenergic fibers contact oligodendrocytes 
at sites that resemble symmetrical synapses, suggesting that oligodendrocytes are NE‟s primary 
target
48
.  NE binds to and activates  and - ARs. Oligodendrocytes express both -1 and -
ARs
37, 49-51
. It has also been shown that activation of -1 adrenergic signaling influenced 
formation of processes and production of myelin. NE increases activity of protein kinase C 





. Alternatively, activation of -adrenergic signaling by NE inhibits proliferation and 
accelerated linage progression. The biological effect of NE is mediated through an increase in 
intracellular cAMP, activity of ERK (extracellular signal-regulated kinase) and of proteins 
essential for the cell cycle arrest. It was suggested that -AR-mediated signaling may be 
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Figure 7. Schematic Representation of the Cortical Noradrenergic Afferents with Neuronal, 
Vascular and Glial Elements.  
Pyramidal and non-pyramidal neurons have been shown to have noradrenergic synapses and 
astrocytes and oligodendrocytes are engaged in discrete anatomical relationships with 
noradrenergic boutons and fibers (As, astrocyte; ASP, astroglial processes; B, basal lamina; Cap, 
capillary; End, endothelial cell; NA, noradrenaline; n-Pyr, non-pyramidal neuron; 0, 




Figure 8. Electron Micrographs of Oligodendroglial Perikarya. 







Figure 9. Norepinephrine Acts on its Target Cells by Binding to and Activating Alpha and Beta-
Adrenergic Receptors (ARs).  
The beta-adrenergic receptor (ßAR) may couple either through Gi or Gs to adenylcyclase in an 
inhibitory or stimulatory fashion, resulting in an increased formation of cyclic AMP and 
activation of protein kinase A (PKA). Activation of alpha adrenergic receptor results in 
activation of PLC. PLC cleaves phosphoinositol diphosphate (PIP2) into diacylglycerol (DAG) 
and inositol triphosphate (IP3). DAG activates PKC, with IP3 causing an increase in (Ca2)i and 







1.5. Effect of Physical Cues on Differentiation 
The physical cues that modify differentiation are defined by mechanical forces and discrete local 
architecture
57, 58
. These conserved and evolutionary ancient features, although largely unknown, 
are the source of many signals. The signals are transduced to the cell nucleus through changes in 
cytoskeleton and complex signaling pathways. For example, it was shown that the fate decision 
of the oligodendrocyte precursors is controlled by both the spatial and geometric characteristics 
of an axonal niche. The critical cell density along an axon provides a mechanical stimulus 
promoting differentiation, possibly through alteration of the size or shape of the cells
59
.  Another 
example presented studies with mesenchymal stem cells (MSCs), where it was demonstrated that 
the size of the substrate pattern regulated cell shape, and cell shape through cytoskeletal tension, 
controlled the lineage commitment
60
. The MSCs‟ fate has also been directed by the elasticity
 
of 
the matrix resembling the specific tissue environment
61
. Hickman‟s group has previously 
demonstrated how physical as well as chemical cues control the function of endothelial and 
neuronal cells. In these studies, chemically defined surfaces and media were used to direct cell 








Figure 10. Schematic Illustration of the Role of Cell Shape and Cytoskeletal Tension in the 
Differentiation of MSCs.  
When an uncommitted mesenchymal stem cell is plated on either a small (left) or large (right) 
island of fibronectin (blue lines), the consequent effect on cell shape, Rho GTPase activity, and 
cytoskeletal tension regulates the commitment to either the adipogenic or osteogenic lineage
67
. 
1.6. Differentiation of Human MLPCs from Umbilical Cord into Glia 
In this study it was investigated whether the control of environmental conditions could induce 
differentiation of human adult stem cells into glia. Adult stem cells were utilized because they 
provide many advantages over fetal or embryonic stem cells. Adult stem cells are relatively 
abundant and easy to isolate. Furthermore, they are less likely to be rejected and do not appear to 
cause tumors after transplantation. Finally, there are no ethical considerations in harvesting adult 
stem cells. The adult stem cells in this study were human umbilical cord stem cells (hMLPCs).  
15 
 
The first goal of the study was to determine the effect of soluble environmental factors on 
differentiation of umbilical cord stem cells into oligodendrocytes. The soluble factors were 
represented by a number of molecules involved in stem cell differentiation or oligodendrocyte 
development. The major target was NE, previously shown to be involved in both stem cell 
differentiation and oligodendrocyte development
43, 46, 48, 68
.  NE is known to activate  and  
adrenergic receptors expressed by its target cells, resulting in activation of associated 
downstream signaling pathways. The soluble factors alone in the standard 2D conditions were 
able to induce differentiation of hMLPCs along the initial stages of oligodendrocyte lineage. 
The next goal was to investigate the effect of surface chemistry and geometry on differentiation 
of hMLPCs into oligodendrocytes. Previously published studies indicated that surface chemistry 
and geometry influenced stem and progenitor cell differentiation. For example, MSCs on large 
fibronectin islands differentiated into osteoblasts, while MSCs on small islands differentiated 
into adipocytes
60
. However, the effect of surface chemistry and geometry on the glial 
differentiation of adult stem cells was not known. In order to recreate the right in vivo 
environment, with biology and engineering interacting at multiple levels, a novel 3D 
environment was constructed which guided differentiation of hMLPCs from umbilical cord into 
oligodendrocytes. The 3D environment was constructed from two sandwiched coverslips. The 
limited space between coverslips provided a defined environment within which cells resided and 
differentiated as well as provided surface cues to the top and bottom of the cells. All parameters 
were known and controllable. In the 3D environment, hMLPCs developed into oligodendrocytes 
and expressed the mature oligodendrocyte marker MBP. To facilitate oligodendrocyte functional 
assembly and to promote myelination in vitro, hMLPCs were co-cultured with rat embryonic 
16 
 
hippocampal neurons (EHNs). To examine whether the structural dimensions of the axon and the 
expression of membrane-bound axonal signals could provide sufficient physical cues for 
differentiation, the co-culture was performed in 2D and 3D culture conditions. The results 
indicated that after growth factor removal, hMLPCs developed into terminally differentiated 
oligodendrocytes in both 2D and 3D and wrapped their processes around the axons. To date, 
oligodendrocytes have been produced mostly from embryonic or fetal stem cells by other 
researchers. Differentiation of hMLPCs in vitro could generate an unlimited numbers of 
oligodendrocytes for studies of various differentiation stages or for transplantation to treat 
demyelinating diseases.   
Finally, similar methodology was examined to determine if astrocytes could be differentiated 
from hMLPCs. It is known that oligodendrocytes and type 2 astrocytes develop from a common 
bi-potential progenitor
28, 30, 69
. Astrocytes have been generated mostly from neural or embryonic 
stem cells by activation of several sets of ligands and receptors. For example, it has been shown 
that bone morphogenetic factors (BMPs) increase the percentage of astrocytes from neural stem 
cells while decreasing the production of neurons and oligodendrocytes
70, 71
. Differentiation to 
astrocyte fate has been also accomplished by increased activity of leukemia inhibitory factor 
(LIF), basic FGF (bFGF), Notch signaling or with ciliary neurotrophic factor (CNTF)
70, 72-81
. It 
has been demonstrated that CNTF caused transient commitment of O2-A progenitors toward a 
type 2 astrocyte fate
73, 82
.  A stable astrocyte fate has been achieved only in the presence of 
extracellular matrix-associated molecules, confirming the significance of environmental cues 
during cell differentiation and fate commitment. However, there are no published studies using 
NE to differentiate stem cells into astrocytes. In this study, astrocyte fate was achieved only in 
17 
 
the presence of physical cues provided by rat embryonic hippocampal neurons.  After the 
induction of hMLPCs differentiation by NE and by physical contact with neurons, human 
astrocytes were separated from rat neurons by a density gradient and cultured further as a pure 
human astrocyte population. These results enable human astrocytes generated from the umbilical 
stem cells to be readily obtained and it would overcome many ethical issues associated with the 














2. MATERIALS AND METHODS 
2.1. Modification of Surfaces 
Glass coverslips (18x18mm
2
, VWR,) were cleaned using HCl/methanol (1:1), soaked in 
concentrated H2SO4 for 2 hrs and then rinsed in double deionized H2O. Coverslips were then 
boiled in deionized water, dried with nitrogen and cured at 110 °C in an oven. The 
trimethoxysilylpropyldiethylenetriamine (DETA, United Chemical Technologies), tridecafluoro-
1,1,2,2-tetrahydroctyl- 1-trichlorosilane (13F, Gelest) and poly(ethylene glycol) (PEG, Sigma 
Chemical Co., St. Louis, MO) monolayers were formed by the reaction of the cleaned surfaces 
with a 0.1% (v/v) mixture of the organosilane in toluene (Fisher T2904). The DETA coverslips 
were heated to just below the boiling point of toluene for 30 min, and then rinsed with toluene, 
reheated to just below the boiling temperature, and then oven dried. Surfaces were characterized 




2.2 Patterns Preparation 
DETA/13F or DETA/PEG SAMs patterns were utilized in order to determine interaction on 
single cell level. These patterns consist of a co-planar monolayer of non-permissive and 
permissive regions: 13 F or PEG are the non-permissive, cytophobic regions of the DETA/13F or 
DETA/PEG SAMs patterns, respectively, while DETA monolayer is the permissive, cytophilic 
region of the SAMs patterns in both cases. Different approaches have been undertaken in order 
19 
 
to prepare the 2 types of SAMs patterns: the DETA/13F SAMs patterns were made by first 
patterning the DETA monolayer followed by a 13F backfill, while the DETA/13F SAMs patterns 
were made by patterning the PEG monolayer followed by a DETA backfill. The SAMs of DETA 
or PEG were patterned using a deep UV (193 nm) excimer laser (Lambda Physik) at a pulse 
power of about 200 mJ and a frequency of 10 Hz for 45 seconds through a quartz photomask 
(Bandwidth Foundry, Eveleigh, Australia). The photomasks used in the patterning process 
differed also, depending on the type of SAMs patterns prepared, DETA/13F or DETA/PEG, 
respectively: a “positive” photomask consisting of chromium patterns on a transparent, quartz 
background (DETA/13F SAMs patterns), and a “negative” photomask consisting of transparent 
patterns on chromium background (DETA/PEG SAMs patterns). The energy dosage (8-15 J/cm
2
) 
was sufficient to ablate the regions of the SAMs monolayer exposed to the UV light, and yield 
reactive hydroxyl groups. The irradiated surfaces (DETA-derivatized SAMs or PEG- derivatized 
SAMs) were subsequently rederivatized with 13F, or DETA, respectively. The rederivatization 
with 13F was done in an inert atmosphere by the reaction of the irradiated surfaces with a 0.1 % 
(v/v) solution of 13F (Gelest, SIT8174.0) in dry chloroform (Sigma Aldrich, cat# 439142) for 5 
min. The rederivatization with DETA was done as described above, but at lower temperature, 
60°C.   
2.3. Contact Angle Measurements 
Water contact angle measurements were measured with a Ramé-hart goniometer (Mountain 




2.4. X-Ray Photoelectron Spectroscopy 
The XPS characterization of DETA and PEG-silane surfaces was done with a Thermo 
ESCALAB 220i-XL X-Ray photoelectron spectrometer equipped with an aluminium anode and 
a quartz monochromator. The surface charge compensation was achieved by using a low-energy 
electron flood gun.  Survey scans were recorded in order to determine the relevant elements (pass 
energy of 50 eV, step size= 1 eV). High resolution spectra were recorded for Si 2p, C 1s, N 1s, 
and O 1s (pass energy of 20 eV, step size= 0.1 eV).  
The spectrometer was calibrated against the reference binding energies of clean Cu, Ag and Au 
samples. In addition, the calibration of the binding energy (BE) scale was made by setting the C 
1s BE of carbon in a hydrocarbon environment at 285 eV. N 1s and Si 2p peak deconvolution 
was performed with Avantage version 3.25 software, provided by Thermo Electron Corporation. 









N 1s/Si2p x 5000 = 1575
Contact angle = 48-50
 






2.5. hMLPCs Cell Culture 
hMLPCs, human umbilical cord blood-derived clonal cell lines, passage 5, were purchased from 
BioE Inc., St. Paul, MN. The cells were cultured in tissue-culture treated T-75 flasks and 
maintained in growth medium, Dulbecco‟s Modified Eagle Media–high glucose (DMEM, Gibco 
BRL, Rockville, MD), with the addition of 15% fetal bovine serum (Stem Cell Technologies, 
Vancouver, BC) and 1% Antibiotic Antimycotic (Gibco BRL) at 37°C in humidified atmosphere 
containing 5% CO2. The medium was changed every 3-4 days. Cells were passaged by 
trypsinization (0.05% trypsin/EDTA solution; Gibco BRL) upon reaching 60% confluence and 
replated at a 1:3 ratio. Passage 8 was used for the experiments unless otherwise indicated. 
 
2.6. EHNs Cell Culture 
All applied procedures were approved by the Institutional Animal Care and Use Committee of 
UCF. The protocol was modified from previously published work for embryonic rat 
hippocampal cultures
65, 66, 84-86
.  Pregnant rats, 18 days in gestation obtained from Charles River, 
were euthanized with carbon dioxide and the fetuses were collected in ice cold Hibernate E 
(BrainBits)/B27/GlutamaxTM/Antibiotic-Antimycotic (Invitrogen) (dissecting medium). Each 
fetus was decapitated and the whole brain was transferred to fresh ice cold dissecting medium. 
After isolation, the hippocampi were collected in a fresh tube of dissecting medium. 
Hippocampal neurons were obtained by triturating the tissue using a Pasteur pipette. In order to 
remove any debris from damaged cells the 1 ml cell suspension was layered over a 4 ml step 
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gradient (Optipep diluted 0.505: 0.495 (v/v) with the dissecting medium and then made to 15%, 
20%, 25% and 35% (v/v) in the dissecting medium) followed by centrifugation for 15 min at 800 
g and 4
0
C. After centrifugation, one strong band of cells was obtained. This band of cells was 
resuspended in culture medium (Neurobasal/B27/GlutamaxTM/Antibiotic-Antimycotic) and 
plated at a density of 100 cells/mm
2
 on DETA coated coverslips or at a density of 75 cells/mm
2
 
on line pattern coverslips. 
 
2.7. Induction of Oligodendrocyte Differentiation 





in growth medium. After 3 days, at 60% confluence, the cells were incubated for 24 hours in  
pre-induction medium, consisting of DMEM, 15% FBS, bFGF, EGF (10 ng/ml each, R & D 
Systems, Minneapolis, MN) and PDGF-AA (10 ng/ml, Chemicon International, Temecula, CA). 
Pre-induction medium for neuronal differentiation was composed of DMEM, 15% FBS and 
bFGF (20 ng/ml). To initiate differentiation, the pre-induction medium was removed, the cells 
were washed 2x with Hanks' balanced salts solution (Gibco BRL) and transferred to serum free 
differentiation medium. Differentiation medium was composed of DMEM, N2 supplement (1%, 
Gibco BRL), 10 µM forskolin, 5 U/ml heparin (Sigma, St. Louis, MO), 5 nM K252a, bFGF, 
EGF, PDGF-AA (10 ng/ml each) and 20 µM NE (Sigma). The differentiation medium was 
changed every other day, while NE was added daily. For agonist experiments, norepinephrine 
was substituted with either the α1-adrenoceptor agonist isoproterenol or the β-receptor agonist 




EHNs were plated on DETA coated coverslips in hippocampal culture medium.  After 4 days, 
half of the culture medium was replaced with serum free pre-induction medium consisting of 
DMEM, N2 supplement (1%, Gibco BRL), bFGF, EGF (10 ng/ml each, R & D Systems, 
Minneapolis, MN) and PDGF-AA (10 ng/ml, Chemicon International, Temecula, CA). After 24 
hrs, another half of the medium was replaced with pre-induction medium and hMLPCs were 




. After 24 hrs, half of the pre-
induction medium was replaced with differentiation medium, composed of DMEM, N2 
supplement (1%, Gibco BRL), 10 µM forskolin, 5 U/ml heparin (Sigma, St. Louis, MO), 5 nM 
K252a, 20 µM NE (Sigma), and with or without bFGF, EGF, PDGF-AA (10 ng/ml each).  24 hrs 
later, another half of the differentiation medium was replaced.  After this medium replacement, 
half of the differentiation medium was changed every other day, while NE was added daily.   
 
2.9. Construction of 3D Environment 
hMLPCs were plated on DETA-coated glass coverslips (18 mm) in growth medium. At 60% 
confluence, growth medium was replaced with pre-induction medium. After the medium 
replacement, another set of coverslips was placed on the top of the cells. Prior to the placement, 
the top coverslips were ethanol sterilized and washed in the pre-induction medium. After 24 
hours the pre-induction medium was removed, the cells were washed 2x with Hanks' Balanced 
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Salts Solution and transferred to serum free differentiation medium. The differentiation medium 
was changed every other day and NE was added daily. 
2.10. Morphological Analysis 
Phase-contrast images were taken with a commercial Nikon Coolpix 990 camera using the Zeiss 
Axiovert S100 microscope. Pictures were analyzed using Scion Image Software (Scion Corp., 
Frederick, MD).  
2.11. Immunocytochemistry 
To characterize cells by immunocytochemistry, the top coverslips, if present, were first carefully 
removed. Cells were then briefly washed with Hanks' balanced salts solution and fixed in 4% 
paraformaldehyde for 18 min. Fixed cells were stored in PBS, permeabilized with 0.5 % Triton 
100x in PBS for 7 min, blocked with 5% donkey serum for 1 hr, followed by incubation with 
primary antibody overnight at 4°C. Primary antibodies were mouse monoclonal A2B5 
(MAB312, 1:250), O4 (MAB345, 1:100), O1 (MAB344, 1:200), MBP (1:25), rabbit polyclonal 
anti-galactocerebroside (AB142, 1:200), Anti-Nuclei (HuNu), (MAB1281, 1:1000), Anti-Glial 
Fibrillary Acidic Protein (GFAP), (AB5804,1:2000), all from Chemicon, mouse monoclonal 
beta-2-AR (sc-81577, 1:200), rabbit polyclonal beta-1AR (sc-567, 1:250,) from Santa Cruz 
Biotechnology, alpha-1-AR (ab3462, 1:1000) and Neuron specific beta III Tubulin (ab18207, 
1:250) both from Abcam Inc., Cambridge, MA. Following a PBS washing, cells were incubated 
with an Alexa Fluor 488-conjugated anti-mouse IgG or Alexa Fluor 488-conjugated anti-rabbit 
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IgG for 2 hours at room temperature. After a PBS washing, the coverslips were mounted with 
Vectashield mounting medium (H1000, Vector Laboratories, Burlingame, CA) onto slides. For 
general visualization of cellular nuclei, the specimens were counterstained with DAPI. 
Immunoreactivity was observed and analyzed by using an Ultra VIEW™LCI confocal imaging 
system (Perkin Elmer).  
 
2.12 Isolation of Astrocytes by Discontinuous Percoll Gradients 
For discontinuous Percoll gradients, 3 ml of 60% Percoll were added to the bottom of a 15-ml 
conical tube.  Another 2 ml of 30% Percoll were slowly overlaid such that there was a sharp 
separation between the two concentrations. Without disturbing the gradient interfaces, the 
gradients were overlaid with 1 ml of the cell suspension. The gradients were transferred to a 
centrifuge and spun 10 min at 150 × g, at 4°C. The astrocyte-enriched fraction migrated to the 
buffer/30% Percoll interface, and the neuron-enriched fraction migrated to the 30%/60% 
interface. The astrocyte enriched layer was carefully aspirated. The cell suspension was 
transferred into a fresh 15-ml conical tube, containing 10 ml DMEM medium, high glucose, and 
centrifuged 10 min at 150 × g, at 4°C. Pelleted cells were resuspended in differentiation medium 




The morphological and immunocytochemical quantification was performed on undifferentiated 
stem cells or cells during various differentiation stages. For each coverslip, at least 10 pictures 
were taken from randomly chosen views under 200x magnification. All the marker-positive cells 
were counted, as well as the total number of cells in these views. At least three coverslips in each 
group were quantified and data were expressed as average ± standard deviation (SD). Statistical 











3.1 Acquisition of Neuronal Morphology 
Motoneurons and oligodendrocyte are sequentially generated from a ventral population of 
neuroepithelial stem cells during development of the CNS
25, 87
. Previous studies demonstrated 
involvement of NE in the differentiation of oligodendrocytes from oligodendrocyte precursors
37, 
48
. Other findings illustrated the influence of NE on development of spinal motoneurons and 
functional maturation of spinal cord
43-45
.  However, the effect of NE on the generation of 
oligodendrocytes or motoneurons from stem cells is not known. Therefore, the influence of NE 
on differentiation of hMLPCs into motoneurons was investigated. Differentiation of stem cells 
along motoneuron or oligodendrocyte lineage is controlled by distinct molecular mechanisms 
influenced by various factors such as PDGF-AA, bFGF, EGF and changes in intracellular cAMP 
levels. These factors along with NE were employed to differentiate hMLPCs in a defined, serum 
free culture system.  First, hMLPCs were plated on trimethoxy-silylpropyl-diethylenetriamine 
(DETA)-coated coverslips and allowed to evenly spread and expanded either for 3 days or to 
60% confluence. At 60% confluence, the culture medium was replaced with the pre-induction 
medium supplemented with bFGF. After 24 hrs, cells were transferred into the differentiation 
medium.   Differentiation medium contained the growth factors bFGF, EGF and PDGF-AA 
along with K252a, heparin, forskolin and NE.  To determine the optimal dosage of NE, hMLPCs 
were treated with different NE concentrations, ranging from 10-500 M. Cells treated with 100-
500 M concentrations of NE exhibited radical morphological changes within the first 4 hrs. Cell 
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bodies become smaller and round with the long process like extensions, resembling the 
morphology of neurons (Figure 12). However, in the continuous presence of NE, cells did not 
survive past 72 hrs. Thus, after 4hrs, once cells assumed neuronal morphology, differentiat ion 
medium was replaced with one deficient in NE. Once in differentiation medium lacking NE, 
cells retained their neuron like morphology for 72 hrs.  
 
 
Figure 12. Phase Images of hMLPCs Treated with 100 M NE for 4 hrs.  
(A) hMLPCs exhibit neuron like morphology at 4 hrs after treatment with 100 M NE. (B) 
Higher magnification image showing neuron like morphology of treated cells. (C) Untreated 
hMLPCs exhibit fibroblast morphology. (D) hMLPCs regained their fibroblast morphology 4 
days after NE removal. Scale bars 100 m. 
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Table 1. Percentage of Cells Exhibiting Neuron-like Morphology in Response to NE. 
 
3.2. Transient Expression of Neuronal Markers 
In order to characterize these neuron like cells, immunocytochemical analysis was performed for 
expression of neuronal markers at 17, 36 and 72 hrs post induction (Figure 13). First, cells were 
stained for expression of nestin, known to be expressed by neural stem cells and progenitor cells. 
Results indicated that at 17 hrs post-induction 28.9±4.1% of the cells expressed nestin. But after 
36 hrs post induction all nestin expression was lost, suggesting the cells could progress to a more 
differentiated stage. Staining with neuronal marker IIIT revealed positive staining in 49.5±3.7% 
of cells 17 hrs post induction and in 13.3±4.8% of cells 36 hrs post induction. These cells also 
expressed motoneuron marker transcription factor Hb9, 87.2±12.5% at 17 hrs and 94.2±3.3% at 
36 hrs post induction. However, 72 hrs after the treatment, the expression of neuronal markers 





Figure 13. Transient Expression of Motoneuron Markers 17 hrs after Treatment with 100 M 
NE.  
(A) hMLPCs transiently expressed nestin, IIIT and Hb9 after the treatment. (B) Higher 
magnification images showing co-expression of nestin and IIIT. All scale bars 100 m. (C) 
Expression of neuronal markers 17 and 36 hrs after treatment. Error bars represent the SD. 
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To examine the effect of low dosages of NE on differentiation of hMLPCs, the cells were treated 
with 10, 20, 30 and 50 M of NE daily (Table 2). Treatment with 10 M NE did not induce any 
significant morphological changes within the first 2 weeks of treatment. Treatment with 30 M 
resulted in increased cell death and treatment with 50 M resulted in cell death within the first 
week. However, when cells were treated with 20 M of NE daily, 67.1±7.7% of cells slowly 
contracted and developed multiple processes, resembling immature oligodendrocyte precursors, 
within 8 days of treatment. 






3.3. hMLPCs and Oligodendrocytes May Share Neuroepithelial Origin 
Oligodendrocytes and motoneurons arise from the Sox1 positive neuroepithelium during 
development. Induction of oligodendrocyte fate is characterized by expression of A2B5 and 
PDGFR-α
30, 88
. In order to explore whether untreated hMLPCs could have some neuroepithelial 
or oligodendrocyte progenitor characteristics, immunocytochemical analysis for expression of 
Sox1, A2B5 and PDGFR-α was performed. The results indicated that untreated hMLPCs were 
Sox1 positive. This suggested that hMLPCs, like oligodendrocytes, originate from the 
neuroepithelium. Untreated cells were PDGFR-α positive and A2B5 negative but expressed 
PDGFR-β (Figure 14). The negative expression of A2B5 and positive staining for PDGFR-β 
distinguished the untreated hMLPCs from oligodendrocyte progenitor cells. These results are 
interesting when compared to recently published findings demonstrating that Sox1+ 








Figure 14. Immunocytochemical Analysis of Untreated hMLPC Suggest Neuroepithelial Origin.  
Untreated hMLPCs expressed the neuroepithelial marker Sox-1, stained positively for PDGFR-α, 












3.4. Differentiation of hMLPCs in a 2D Environment 
The development to an oligodendrocyte phenotype is influenced by factors such as PDGF-AA, 
bFGF, EGF and changes in intracellular cAMP levels. Based on these mechanisms, hMLPCs 
were induced to differentiate into the initial stages of the oligodendrocyte lineage in a defined, 
serum free culture system. Prior to differentiation, the hMLPCs were plated on DETA-coated 
coverslips and allowed to evenly spread and expanded either for 3 days or to 60% confluence. It 
was observed that higher cell densities reduced the differentiation efficiency, whereas low cell 
density negatively affected the survival. When the cells were 60% confluent, the culture medium 
was replaced with the pre-induction medium supplemented with bFGF, EGF and PDGF-AA. 
After 24 hrs, cells were transferred into the differentiation medium.   Differentiation medium 
contained the growth factors bFGF, EGF and PDGF-AA along with K252a, heparin, forskolin 
and NE. The essential differentiation factors were NE, forskolin and K252a, as the desired 
morphology was not observed in the absence of any of these factors (Figures 15B, 15C, 15D). 
Both forskolin and K252a are factors frequently used during different stages of stem cell 
differentiation; however norepinephrine emerged as the novel stem cell differentiation factor that 
uniquely promoted the hMLPCs along an oligodendrocyte lineage. Absence of the growth 
factors increased the differentiation rate but resulted in decreased survival and less elaborate 
process formation (Figure 15E). After the transfer into the differentiation medium, the hMLPCs 
exhibited cell shape changes, from that of a fibroblast morphology (Figure 15A) to refractile cell 
bodies. Within 8 days of differentiation, approximately 70% of cells developed multiple 
processes and Figures 15F, 15G and 15H reflect the morphology development at day 15. During 
the process, a close correlation between the passage number and the differentiation potential was 
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observed. The most favorable outcome for differentiation of the hMLPCs was found when 
utilizing cells from passage 8. Earlier passages did not respond as well to the treatment and 
retained higher proliferation rates. Later passages exhibited a somewhat decreased differentiation 











Figure 15. Phase Contrast Images of Differentiating hMLPCs in 2D Environment.  
Undifferentiated (Und) hMLPCs exhibited fibroblast morphology. Cells at 15 days in 
differentiation medium without NE, forskolin (-For) or K252a retained their fibroblast 
morphology. Process formation was visible in the medium without growth factors (-PEF). 
Refractile cell bodies and increased process formation were observed in the presence of all 
factors indicated above (+All). Cells lost their multipolar morphology and became bipolar or 
spindle shaped at day 24. Scale bars, 100 µm, (first two rows 20x magnification, third row 40x 
magnification (+All) and 20x magnification (D24)). 
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Immunocytochemical analysis was performed using the antibodies for specific stages of 
oligodendrocyte differentiation (Figures 16A, 16B). The untreated hMLPCs showed negative 
staining for A2B5 and faint staining for O4. Cells were also negative for the more mature 
oligodendrocyte markers O1 galactocerebroside and MBP. However, at 8 days of differentiation, 
72.4 ± 3.4% of cells exhibited positive staining for A2B5 and 69.9 ± 4.9% for O4, but expression 
of O1 galactocerebroside and MBP was absent at this time period in the 2D environment. The 
results indicated that in response to the treatment, the majority of hMLPCs acquired cellular 
characteristics of immature oligodendrocyte precursor cells. The expression of A2B5 and O4, 
accompanied by a multi-process morphology, persisted to day 15, but the precursors did not 
achieve a fully differentiated oligodendrocyte phenotype. After 15 days of differentiation, cells 
began to lose their multi-process morphology and became mostly bipolar and spindle shaped 
(Figure 15I). At day 20, 35.0 ± 4.8% of cells remained A2B5 positive, 49.7 ± 7.9% O4 positive 
and O1, MBP negative (Figure 16B). In addition, limited cell survival was observed after day 20 








Figure 16. 2D Environment Promotes Differentiation of hMLPCs along Early Stages of 
Oligodendroglial Lineage.  
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(a) Immunocytochemical analysis of differentiating hMLPC in 2D environment. The untreated 
hMLPCs showed negative staining for A2B5 and faint staining for O4. At 15 days of 
differentiation, cells exhibited positive staining for A2B5 and O4, characteristics of immature 
oligodendrocyte precursor cells. (b) hMLPCs do not Differentiate into Committed 
Oligodendrocytes in a 2D Environment. At 8 days of differentiation, 72.4% of cells were 
positive for A2B5 and 69.9% for O4 and at day 15 70.3% of the hMLPCs exhibited positive 
staining for A2B5 and 69.7% for O4. At 20 days, 35.0% of cells remained A2B5 positive and 
49.7% O4 positive. Expression of O1 galactocerebroside and MBP was absent in both untreated 
and differentiating cells. Scale bar, 100 µm, (Rows 1 and 2, 20x magnification and Row 3, 40x 












3.5. Differentiation of hMLPCs in a 3D Environment 
Because it has been shown to be an important feature of cellular development, the effect of a 
simple 3D environment was examined on oligodendrocyte lineage progression. To construct this 
3D environment, cells were differentiated between 2 coverslips. Initially, undifferentiated cells 
were plated onto DETA-coated coverslips at the bottom of 12-well plates. When the cells 
reached 60% confluence, the culture medium was replaced with the pre-induction medium, then, 
after the medium replacement, an unmodified glass coverslip was placed over the top of the 
cultured cells.  In the 3D environment, within 24 hrs significant cell morphological flattening and 
spreading was observed (Figure 17B). After 24 hrs, the pre-induction medium was replaced with 
differentiation medium and there was a further increase in cell flattening (Figure 17C) but within 
10 days of differentiation cells began to form processes and the cell bodies slowly contracted. 
Process development and branching continued for 3 weeks. After 30 days of differentiation, 
approximately 85% of the cells had elaborated an extensive network of processes (Figures 17D, 
17E, 17F). The presence of PDGF was required for process formation, as in its absence cells 
progressed through initial differentiation stages but lost their multi-process morphology after 2 
weeks of differentiation. The presence of bFGF and EGF was not essential but resulted in 





Figure 17. 3D Environment Promotes Further Differentiation of hMLPCs.  
(A-F) Phase contrast images of differentiating hMLPCs. (A) The untreated cells displayed 
typical fibroblast morphology. (B) Cells exhibited flattening and spreading at 24 hrs in 3D 
environment. (C) Cells at 8 days in the differentiation medium displayed increased flattening. (D, 
E, F) At 30 days of differentiation, approximately 80% of cells revealed extensive processes. (G-
I) Growth factors influenced the development of processes. (G, H) Immunostained cells 
displaying increased branching and development of processes in presence of bFGF and EGF. (I) 




Immunocytochemical analysis revealed that after 20 days of differentiation 81.8 ± 6.6% of the 
cells expressed the oligodendroglial marker A2B5 and 80.6 ± 2.9% O4 (Figure 18C). At 30 days 
of differentiation, 57.7 ± 3.6% of the cells stained positively for A2B5, 79.6 ± 2.9% for O4, 42.1 
± 2.7% for the committed oligodendrocyte marker O1 galactocerebroside and 15.2 ± 0.5% for 
MBP (Figures 18A, 18B, 18C). The 3D environment appeared to play a key role during 
differentiation, oligodendrocyte commitment and lineage progression. There was decreased cell 
proliferation and, unlike in the 2D environment, passage numbers did not significantly affect 
differentiation in the 3D environment. Even after the removal of NE from the differentiation 
medium after 20 days, the cells retained their differentiated morphology for an additional 10 









Figure 18. hMLPCs Differentiate into Committed Oligodendrocytes in a 3D Environment.  
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(A) Immunocytochemical analysis of differentiating hMLPCs in a 3D environment. The 
untreated hMLPCs indicated negative staining for A2B5, faint staining for O4 and negative 
staining for O1 galactocerebroside and MBP. At 30 days of differentiation, cells exhibited 
intensely positive staining for A2B5 and O4. Cells also expressed O1 galactocerebroside and 
MBP, characteristic of committed oligodendrocytes. Scale bars, 100 µm, (Rows 1-7, 200x 
magnification and Rows 4-5, 400x magnification). (B) Co-expression of O4 and 
galactocerebroside (GC) in the differentiated cells. At 30 days of differentiation, GC was 
expressed in O4 positive cells. Scale bars, 100 m, (Row 1, 200x magnification and Row 2, 400x 
magnification). (C) The progression of differentiation in a 3D environment. At 20 days of 
differentiation 81.8% of cells expressed the oligodendroglial markers A2B5 and 80.6% O4 and 
were negative for O1and MBP. At 30 days of differentiation, 57.7% of cells stained positively 
for A2B5, 79.6% for O4, 42.1% for committed oligodendrocyte marker O1 and 15.2% for MBP. 









The contribution of the surface chemistry of the top coverslip was also qualitatively investigated 
as previously it has been shown that surface composition can have a dramatic effect on cellular 
response and differentiation
63, 64, 91
. To determine the most appropriate 3D conditions for 
differentiation, the top glass coverslips were also modified with various surface chemistries 
which had been found previously to selectively promote or repel cell adhesion (Table 3). 
Unmodified glass coverslips were used as a control. To promote cell adhesion, the top coverslip 
was coated with a DETA monolayer. This environment, in which cells were attached to both top 
and bottom coverslips, produced initially good differentiation but eventually caused increased 
cell death, possibly due to damage from cell movement during feeding and morphological 
evaluation as the cells were well adhered to both surfaces. For the inverse situation the top 
coverslip was coated with polyethyleneglycol (PEG) or with a non-adhesive fluorinated silane 
(13F) monolayer. The PEG coated top coverslips resulted in good cell survival but a lesser 
degree of differentiation. 13F coated coverslips (contact angle >100º) triggered significant cell 
death. Thus it was determined that the glass coverslips controls were the most suitable top 
surfaces for optimal differentiation, as the cells did not adhere to the glass, and remained on the 









Table 3. Percentage of Cells Developing Processes in Response to Surface Modification. 
 
Data show mean ± SD for three coverslips at day 20 and 30 of differentiation.   










3.6. hMLPCs Express Functional ARs in the 3D System 
To investigate the role of adrenergic signaling mechanisms in oligodendrocyte differentiation 
from the hMLPCs, immunocytochemical analysis was performed for expression of α- and β-
ARs. The findings indicated that hMLPCs already expressed
 
β1-ARs on the cell surface before 
differentiation (Figure 19A). No expression of β2-ARs before or during differentiation was 
detected. Expression of α1-ARs was first observed at the nucleus and the intensity of staining 
significantly increased after treatment with pre-induction medium supplemented with bFGF, 
EGF and PDGF-AA (Figure 19B). Further analysis revealed that bFGF alone was able to 
increase nuclear expression of α1-ARs (Figure 19C) in a time and dose dependent manner 
(results not shown). At day 15 of differentiation the α1-ARs began to relocate to the cell surface. 
At day 30, differentiated cells expressed α1-ARs at the surface of cell bodies and to a lesser 
degree in the processes (Figure 19B). This surface expression was observed only in cells with a 
multi-process morphology, whereas in cells exhibiting a flat morphology, or undifferentiated 
cells, the α1-ARs remained at the nucleus. These studies are consistent with recent findings 
demonstrating nuclear localization of α1-AR
92, 93
. The published studies provided a new model 
for α1-AR signaling, in which a signal is transduced from the nucleus to the plasma membrane, 
and is confirmed in this cellular transformation as well. The same initial expression patterns were 






Figure 19. Expression of α1- and β1-ARs. 
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(a) Positive staining for β1-ARs in undifferentiated cells, cells pre-induced for 24 hrs with bFGF, 
EGF and PDGF-AA, and cells at 30 days of differentiation. Scale bar, 100 µm. (b) Nuclear 
expression of α1-ARs in undifferentiated cells, intensive nuclear staining in cells pre-induced for 
24 hrs with bFGF, EGF and PDGF-AA, and surface expression at 30 days of differentiation. (c) 
Nuclear expression of α1-ARs in undifferentiated cells and evidence of a significant increase in 
















3.7. Activation of Both α- and β-AR is Essential for Differentiation in the 3D System 
To assess the role of each adrenergic receptor in the differentiation process, NE was substituted 
in the differentiation medium with equimolar concentrations of the β-AR agonist isoproterenol, 
the α1-AR agonist phenylephrine or with both agonists. Daily treatment with isoproterenol 
induced morphological changes, cell body contraction and formation of processes within the first 
15 days of treatment. However, approximately 60% of the cells displayed a bipolar morphology 
resembling immature oligodendrocyte progenitors. Cells did not change their bipolar 
morphology within 30 days of differentiation (Figure 20C) and exhibited enhanced cell death. In 
order to characterize these cells, immunocytochemical analysis at day 30 of differentiat ion was 
done. It was observed that 57.9 ± 4.9% of the cells expressed A2B5 and 42.5 ± 2.7% O4, 
however the cells were O1 and MBP negative (Figure 20G). These results demonstrated that 
stimulation of β-AR by isoproterenol induced the initial stages of differentiation. However, β-AR 
treatment alone was not sufficient to direct the MLP cells into a more mature stage of 
differentiation.   
Daily treatment of the hMLPCs with the α1-AR agonist phenylephrine initially resulted in only 
modest effects. Good cell survival was observed but the majority of cells maintained a flat 
morphology. Within 15 days of differentiation approximately 40% of the cells began to develop 
processes, however at day 30, only 15% of the cells exhibited more mature morphology with 
developed processes. The majority of cells showed only partial process development and 
branching or maintained a flat morphology (Figure 20D). Immunocytochemical analysis at day 
30 revealed that 40.5 ± 3.4% of cells stained positively for A2B5, 39.8 ± 2.8% for O4 and 15.2 ± 
1.5% for O1 (Figure 20G). The results suggested that activation of α1-AR could play a role in 
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more advanced stages of differentiation in which cells start to lose expression of A2B5 and begin 
to express O1.   
Daily treatments of cells with both isoproterenol and phenylephrine resulted in formation of 
multiple processes and the treated cells became morphologically similar to those treated with NE 
(Figures 20A and 20B). At day 30 of the differentiation period, 48.7 ± 4.9% of the cells stained 
positively for A2B5, 50.2 ± 1.1% for O4, 28.9 ± 5.2% for O1 and 9.7 ± 0.7% for MBP (Figures 
20F, 20G).  
The results indicate that stimulation of both the α- and β-ARs is required for optimal 
differentiation. This suggests a close interplay between both ARs, ultimately resulting in the 







Figure 20. Influence of ARs on Differentiation of hMLPCs into Oligodendrocytes.  
(a) Phase contrast images of cells at 30 days of differentiation, in the presence of NE, exhibited a 
complex multipolar morphology (A). Cells differentiated for 30 days in the medium where NE 
was substituted by the β-AR agonist isoproterenol and the α1-AR agonist phenylephrine (B). 
Cells were morphologically comparable to cells treated with NE. Cells differentiated in the 
presence of the β-AR agonist isoproterenol frequently displayed bipolar morphology, resembling 
immature oligodendrocyte progenitors (C). Substitution of NE by the α1-AR agonist 
phenylephrine resulted in mature morphology in 10% of the cells. The remainder of the cells 
showed only partial process development or remained flat (D). Cells differentiated for 30 days 
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without activation of ARs by NE or AR-agonists continued to exhibit a mostly flat morphology 
(E). (b) Stimulation of both α1- and β1-ARs is required for optimal differentiation. 
Immunocytochemical analysis of cells differentiated for 30 days in the presence of β-AR agonist 
isoproterenol and the α1-AR agonist phenylephrine. Cells stained positively for A2B5, O4, O1 
and MBP. Scale bars, 100 µm. (c) Comparison of differentiation levels achieved by activation of 
both ARs by NE, by both AR agonists (Iso+Phen), by β-AR by isoproterenol (Iso) and by α1-AR 













3.8. Co-culture of hMLPC with EHNs 
The engineered 3D culture environment provided essential physical cues to guide differentiation 
of hMLPCs into MBP positive oligodendrocytes. To facilitate their functional assembly and to 
promote myelination in vitro, hMLPCs were co-cultured with rat EHNs. It had been previously 
shown that differentiation of oligodendrocyte precursors is controlled by the spatial and 
geometric characteristics of an axonal niche
59
. To examine whether the structural dimensions of 
the axon and the expression of membrane-bound axonal signals could provide sufficient physical 
cues for differentiation, the co-culture was performed in 2D and 3D culture conditions. To 
observe the interaction on single cell level, the cells were plated on DETA line patterns, 
separated by a cell repellent 13F coating.  First, rat EHCs were plated on the coverslips 
containing the line patterns in hippocampal culture medium.  After 4 days, half of the culture 
medium was replaced with serum free pre-induction medium. After 24 hrs, another half of the 
medium was replaced with pre-induction medium. 24 hrs later, hMLPCs were plated on the top 
of EHNs. 24 hrs later, half of the pre-induction medium was replaced with differentiation 
medium, composed of DMEM, N2 supplement, forskolin, heparin, K252a, NE and with or 
without growth factors: PDGF-AA, EGF and bFGF (PEF). 24 hrs later, another half of the 
differentiation medium was replaced.  After this medium replacement, half of the differentiation 
medium was changed every other day, while NE was added daily.  While the morphology of 
EHNs remained unchanged, significant changes were detected in morphology of the hMLPCs.  
Within first 48 hrs of co-culture, the cells contracted and developed rounded cell bodies with 
multiple processes (Figure 21). 3D cultures did not perform well as the cells adhered to both 





Figure 21. Morphological Changes of hMLPCs at 48 hrs after the Co-culture.  
(A) Untreated hMLPCs before the co-culture exhibit fibroblast morphology. (B) Typical 
morphology of EHNs. (C) Rounded cell bodies and multiple processes of hMLPCs after the co-















As cells continued to differentiate, a morphological difference was observed related to the 
presence or absence of growth factors (PEF) in the medium. The difference in cellular 
morphology was markedly evident at 7 days of differentiation and became increasingly 
pronounced with increased differentiation time. Figure 18 reflects the cellular morphology at day 
12. In the presence of growth factors in the medium, cells rapidly proliferated, spread, grew in 
size and developed long processes. Without the growth factors, cells remained smaller and in 
close contact with surrounding cells. A high proliferation rate was not observed, possibly due to 
a lack of growth factors and cellular contact inhibition. With increasing differentiation time, the 
distance between cells became shorter and after 3 weeks of co-culture, cells became so compact 
one could not clearly distinguish their morphology. These morphological changes were observed 
only in hMLPCs in physical contact with neurons. hMLPCs localized in the areas of low 
neuronal density, without physical contact with neurons, remained spindle shaped or flat. This 





Figure 22. Phase Contrast Images of hMLPCs Co-cultured with EHNs.  
(A) EHNs alone.  Co-culture of hMLPCs and EHNs at 12 days of differentiation (B) in the 
absence of growth factors, (C) in the presence of growth factors.  Higher magnification images 
of the co-culture differentiated (D-F) in the presence of growth factors and (G-I) in the absence 





3.9. Differentiating Human Oligodendrocytes can be distinguished from Rat Neurons 
Differentiating hMLPCs were identified by immunocytochemistry using a monoclonal antibody 
against human specific nuclear antigen (HuNu). This antibody does not react with nuclei from 
rat. Rat EHNs were detected by employing neuron specific beta IIIT antibody. Untreated 
hMLPCs did not express neuronal IIIT, and HuNu immunostaining revealed their large nuclei. 
When hMLPCs were co-cultured with EHNs and induced to differentiate, approximately 70% 
cells significantly contracted and reduced in size. The same was true for changes of nuclear 
morphology. As cells continued to differentiate, their nuclei became rounded and substantially 
smaller. No significant changes were observed in the morphology of IIIT stained neurons. 
Immunocytochemical analysis of the co-culture at day 12 revealed that in presence of growth 
factors 66.8±5.8 % of the cells stained positive for HuNu and 40.4±5.5% of the cells stained 
positive for IIIT.  In absence of growth factors, 48.8±3.1% of the cells expressed HuNu and 
55.6±3.3% expressed IIIT.  The results of both conditions indicated that the human derived 




Figure 23. Immunocytochemical Analysis Distinguished hMLPCs from Rat EHNs.  
(A) hMLPCs stained positively for human specific HuNu and negatively for IIIT. EHNs did not 
stain for HuNu but expressed the neuronal marker IIIT.  The hMLPC and EHN co-culture at 
day 12 of differentiation showed positive staining for both HuNu and IIIT.  Scale bars 100 m.  
(B) hMLPCs alone stained 100% positively for HuNu and were negative for IIIT. EHNs alone 
stained 100% positively for IIIT but did not express HuNu. Co-culture at day 12 in the 
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differentiation medium containing PEF revealed that 66.8±5.8% of the cells stained positively 
for HuNu and 40.4±5.5% cells stained positively for IIIT.  In absence of PEF, 48.8±3.1% of the 





















3.10. hMLPCs Differentiate into Mature Oligodendrocytes in the Presence of EHNs 
Differentiated cells were identified by immunocytochemical analysis for expression of 
oligodendroglial markers (Figure 24A). Results revealed that at 14 days of differentiation, in the 
presence of growth factors, 48.9±6.2% of the co-cultured hMLPCs expressed the bipotential 
oligodendrocyte/astrocyte progenitor marker A2B5 and 17.1±3.4% of cells expressed the early 
oligodendroglial marker O4 (Figures 24A and B). It was observed that the O4 positive cells were 
localized exclusively in the areas of highest cell density. Cells were negative for O1 and MBP. 
However, 39.3±4.6% of the co-cultured cells stained positively for the astrocyte marker glial 
fibrillary acidic protein (GFAP). These cells progressively exhibited long and sparsely branched 
processes, typical of type II astrocytes (Figure 24A). Some of the GFAP positive cells reached 
sizes up to 200 m.  These results suggested that in presence of growth factors, oligodendroglial 
differentiation of hMLPCs was arrested at the A2B5/O4 stage. It appeared that growth factors 
influenced the fate choice of proliferating bipotential A2B5 progenitors to become GFAP 
positive astrocytes. In absence of growth factors 44.2±5.3% of the cells stained positively for 
A2B5, 55.6± 3.3% for O4, 20.2± 1.9% for the committed oligodendrocyte marker O1 and 
11.9±4.2% for MBP (Figures 24A and B).  The O4, O1 and MBP positive cells were 
concentrated in the most cell dense regions. The results indicated that after growth factor 
removal, hMLPCs developed into terminally differentiated oligodendrocytes. These findings are 
consistent with previously published studies describing oligodendrocyte generation from A2B5 
positive progenitors
36, 94-96
. In these studies the progression from progenitor to myelinating 
oligodendrocyte entails a sequence of events, initiated by withdrawal of PDGF-AA and bFGF 
growth factors. This contributed to cell cycle withdrawal and cytoskeletal changes. In the 
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presence of neurons, terminally differentiated oligodendrocytes then wrapped their processes 










Figure 24. Immunocytochemical Analysis of Co-cultures Differentiated for 14 Days.  
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(A) In the absence of PEF, differentiated hMLPCs expressed the early and late oligodendrocyte 
markers A2B5, O4, O1 and MBP. In the presence of PEF cells did not progress into mature 
oligodendrocytes. Scale bars 100 m. (B) In the presence of PEF, 48.9±6.2% of the co-cultured 
cells expressed the bipotential glial progenitor marker A2B5 and 17.1± 3.4% the marker O4 and 
were negative for O1 and MBP. In absence of PEF, 44.2±5.3% of the cells stained positively for 
A2B5, 55.6± 3.3% for O4, 20.2± 1.9% for the committed oligodendrocyte marker O1 and 


















3.11. Differentiated Oligodendrocytes Wrap around Axons in Culture 
The primary function of oligodendrocytes is to produce the myelin sheath, which insulates axons 
of the CNS and facilitates rapid saltatory conduction of action potentials. To investigate whether 
the newly differentiated oligodendrocytes were functional and capable to myelinate the axons of 
rat EHNs, co-cultures were examined at day 21 by immunocytochemical analysis.  At day 21, in 
the differentiation medium without growth factors, MBP positive oligodendrocytes exhibited 
elaborate processes and acquired a typical stellate appearance.  It was observed that numerous 
primary processes of these cells emerged from the cell body and divided to form secondary 
processes. Tertiary processes then established interconnections between primary and secondary 
ones. These interconnections tended to appear first close to the cell body and then expanded 
further (Figures 25C and D). In the areas with high axonal density, oligodendrocytes aligned 
their processes along the length of axons and wrapped them around axonal fibers, that were 




Figure 25. Immunocytochemical Analysis of Mature Oligodendrocytes.   
(A) Oligodendrocytes wrapping their processes around axons. Scale bar 100 m. (B) Mature 
oligodendrocytes wrapped around an axon. Scale bar 50 m. (C-D) Morphology of mature 







3.12 Generation of Pure Astrocyte Population 
In order to generate a pure astrocyte population, differentiated astrocytes were separated from rat 
neurons using a density gradient. For this purpose, cells were trypsinized of the culture surface at 
day 5 of co-culture and passed through a Percoll gradient.  The small neurons passed through the 
30% Percoll and come to rest on a cushion of 60% Percoll. The larger, membranous astrocytes 
stopped at the medium/30% Percoll interface. 
 
 
Figure 26. Percoll Gradient Separation of Astrocytes
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. 
Isolated astrocytes were than replated on DETA coated coverslips and cultured further in the 
differentiation medium. After 5 days, immunocytochemical analysis was performed for the 




The results indicated a pure human derived astrocyte population (Fig.27) 
 
















Motoneurons, oligodendrocytes and astrocytes are produced during CNS development from a 
restricted domain of the ventral ventricular zone, termed the pMN domain
98
.  These cells 
sequentially arise from Sox-1 positive neuroepithelial cells of the neural tube
16-18
. In this study, 
functional oligodendrocytes were generated from Sox-1 positive hMLPCs from human umbilical 
cord. It is possible that hMLPCs, like cells of the CNS and early waves of multipotent MSCs, 
originate from neuroepithelium during development
89, 90
. hMLPCs from umbilical cord are 
collected at birth and have the potential to give rise to all three embryonic layers
99
. This study 
has indicated that hMLPCs display extreme sensitivity to their environment. Their fate depends 
not only on soluble factors but also on the surrounding physical cues. The combination of these 
external signals, processed through signal transduction networks, altered the cell morphology, 
induced transitional expression of motoneuron markers and finally, influenced fate decision to 
differentiate along the oligodendrocyte linage. Various published findings have illustrated the 
influence for NE on development of spinal motoneurons and the functional maturation of spinal 
cord
43-45
. For example, it was illustrated that noradrenergic innervations of the ventral horn 
rapidly peaks during development of the spinal cord and then declines at the end of neonatal life 
to the values found in the young adult. The rapid increase of NE levels during prenatal 
development suggests a significant role for NE in the differentiation of motoneurons. In other 
studies, electron microscopy images have provided evidence for direct noradrenergic control of 
oligodendroglial and astroglial cells throughout the cortex
48
. Oligodendrocytes were the major 
target of the noradrenergic fibers, exhibiting a light thickening at the sites of contact. It was 
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reported that oligodendrocytes expressed α1 and β-ARs and their activation by NE accelerated 
differentiation of the oligodendrocyte precursors
37, 49, 51
. In spite of this, there were no known 
studies using NE as a key factor to induce differentiation of stem cells into oligodendrocytes. To 
explore this possibility, hMLPCs were analyzed for expression of ARs, and it was found that the 
undifferentiated cells expressed both α1-ARs and β1-ARs. The β1-ARs were localized on the 
surface before and during the differentiation. Surprisingly, typical surface expression of the α1-
ARs was not observed; instead, the α1-ARs were localized at the nucleus. The intensity of 
nuclear staining significantly increased after treatment with bFGF. However, as the cells 
exhibited a more differentiated phenotype after 15 days of differentiation and then relocation of 
α1-ARs to the surface was observed. Nuclear localization of α1-ARs is consistent with a recently 
proposed model for α1-AR signaling in cardiac myocytes. In this new model, activation of α1-
AR signaling is initiated at the nuclear membrane and results in localization of activated ERK in 
calveolae at the plasma membrane
92, 93
. 
Differentiation was initiated by the transfer of hMLPCs into the differentiation medium in a 2D 
environment. The differentiation medium contained NE along with forskolin, K252a, heparin, 
PDGF-AA, bFGF and EGF. Within 8 days in the differentiation medium, process formation was 
observed and immunocytochemical analysis indicated a positive reactivity to A2B5 and O4 
primary antibodies. In spite of this, cells did not progress further along the oligodendrocyte 
lineage. After 2 weeks in differentiation medium, cells exhibited bipolar and spindle like 
morphology and remained A2B5 and O4 positive, but O1 negative, and prolonged differentiation 
time also significantly increased cell death. 
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A 3D microenvironment was constructed to combine chemical and physical cues shown to 
influence lineage commitment during development in other systems.  The hMLPCs 
responded to the 3D environment initially by cell flattening and later, within 2 weeks of 
differentiation, formation of processes. At 30 days, 42.1 ± 2.7% of cells expressed the O1 
antigen, indicating terminally differentiated oligodendrocytes, and 15.2 ± 0.5% of the cells 
expressed MBP with increased cell survival. The differentiated cells survived for more than 40 
days in culture. Importantly, the oligodendrocytes retained their differentiated state even after 
removal of the NE after 20 days.  
It is well established in other systems that after removing growth factors from the medium, 
oligodendrocyte precursors exit cell cycle, stop dividing and terminally differentiate 
100-102
. In 
our system, more complex branching, process development and increased survival was 
demonstrated in the presence of growth factors. This could be explained by the combined effect 
of forskolin and norepinephrine. Both factors are known to increase cAMP levels, and increased 
cAMP levels inhibit proliferation of oligodendrocyte precursors
37, 103
. Thus, the removal of 
growth factors was not essential for cell cycle exit and terminal differentiation. Decreased 
proliferation with increased cell flattening and spreading was also observed after the introduction 
of the top coverslip. 
It has also been demonstrated previously that stimulation of β-ARs induces differentiation 
through an increase in intracellular cAMP and through the activation of proteins known to be 
involved in cell cycle arrest
37
. There are also studies revealing that p38MAPK and Erk1/2 have 
roles in differentiation of oligodendrocyte progenitors
104
. Both ARs can activate p38MAPK 
while Erk1/2 is a downstream target of α1-AR. It was shown in these studies that p38MAPK 
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activity was required for the progression of bipolar early progenitors (A2B5+, O4-) to multipolar 
late progenitors (O4+, O1-), and Erk1/2 activity was essential for progression of late progenitors 
to oligodendrocytes
36
.   
Our results indicated that the majority of cells treated with the β-AR agonist isoproterenol 
remained bipolar even after 30 days of differentiation. Immunocytochemical analysis indicated 
differentiation arrest at the stage where A2B5+ cells began to express O4, perhaps due to 
insufficient activation of Erk1/2 signaling. In contrast, cells treated with the α1-AR agonist 
phenylephrine showed higher survival and after 30 days of differentiation 15.2 ± 1.5% of cells 
had progressed to the O1+ stage, possibly due to increased stimulation of the Erk1/2 signaling 
pathway. However, simultaneous activation of both receptors by NE, or by both agonists, was 
the best strategy, possibly by supplying the optimal cAMP levels and stimulating essential 
signaling pathways engaged in the close interplay during differentiation. This study 
demonstrated the significance of cellular microenvironment as a driving force in human stem cell 
differentiation. A 3D environment was constructed and a novel small molecule was utilized to 
induce differentiation of hMLPCs, whereas neither condition alone produced functional 
differentiation. The mechanical cues in combination with soluble factors influenced the 
progression of hMLPCs along the oligodendrocyte lineage.   
To investigate whether hMLPCs‟ derived human oligodendrocytes are functional and capable to 
myelinate axons, hMLPCs were co-cultured with rat EHNs.  Because axons could also provide 
physical cues to influence functional differentiation, the co-culture was performed in 2D as well 
as 3D conditions. Our results indicated that structural dimensions of the axons and the expression 
of membrane-bound axonal signals provided sufficient physical cues for differentiation in 2D 
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conditions. In co-culture, hMLPCs differentiated into mature oligodendrocytes or astrocytes 
based on presence/absence of growth factors in differentiation medium. In the absence of PDGF-
AA, EGF and bFGF, hMLPCs differentiated into oligodendrocytes.   
At day 21, in the differentiation medium, MBP positive oligodendrocytes exhibited elaborate 
processes and acquired a typical stellate appearance.  The formation of elaborate processes was 
observed and in the areas with high axonal density, oligodendrocytes aligned their processes 
along the length of axons and wrapped them around the rat axonal fibers, as revealed by 
immunocytochemical analysis at day 21. 
In the presence of PDFGF-AA, EGF and bFGF, hMLPCs differentiated into astrocytes and 
stained positively for astrocyte markers GFAP and S100, and for human markers HuNu and 
human specific microtubule marker. These results support a sequential model for motoneuron-
glia differentiation, in which astrocytes are generated in sequential order from proliferating stem 
cells, after establishment of motoneurons and oligodendrocytes. It is well known that PDGF-AA, 
EGF and bFGF have a positive effect on stem cell proliferation. Thus, increased proliferation 
time could be one of the key factors responsible for astrocyte fate in this system.  The 
responsiveness of differentiating astrocytes to NE was expected. Both astrocytes and 
oligodendrocytes are contacted by noradrenergic synaptic terminals and astrocytes, like 
oligodendrocytes, express alpha and beta adrenergic receptors.  
To generate a pure population of human astrocytes, cells were separated from neurons utilizing a 
Percoll density gradient. After the separation, the cells were replated to produce a homogenous 
culture and the differentiated astrocytes exhibited large rounded cell bodies with long processes, 
morphologically resembling protoplasmic astrocytes. Cells were surprisingly large in size, some 
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reaching over 200 m. These observations could be explained by previously published findings 




These studies demonstrated for the first time methods for obtaining human oligodendrocytes and 
astrocytes in high yield from human umbilical cord stem cells in defined and controllable 
environmental conditions. Alternative differentiation into oligodendrocytes or astrocytes was 
achieved entirely by environmental control. Furthermore, unlike other studies employing sonic 
hedgehog signaling, NE was utilized as a novel differentiation molecule and noradrenergic 
signaling as a novel route to attain a glial fate from adult stem cells. 
Human umbilical cord stem cells are a highly promising source of cells for tissue regeneration
105
. 
Compared to adult stem cells obtained from bone marrow, these cells are immature and elicit a 
lower incidence of graft rejection, graft-versus-host disease and low post transplant infections
105
. 
Besides this biological superiority, these stem cells are abundantly available and routinely 
harvested without risk to the donor
106
. Compared to embryonic stem cells, obtained from human 
embryos, human umbilical cord stem cells are not only easily obtainable, but also could be more 
suitable for cellular therapeutics.  Embryonic stem cells have been associated with reports of the 
uncontrollable development of teratomas in a syngeneic transplantation model, imprinting-
related developmental abnormalities and ethical issues. Human umbilical cord stem cells, readily 
available and differentiated by environmental signals, offer an added potential therapeutic 
advantage. These cells can be used as a source of cells for cellular therapeutics at this particularly 
tenuous time for embryonic stem cell research, after a federal ruling that undercut government 
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funding for many initiatives in the field, including Geron Corporation. Human cells obtained 
from umbilical cord can represent the next wave: living cells as therapeutics. 
Future studies will expand understanding of the role of the microenvironmental signals and 
noradrenergic signaling in the glial differentiation.  Terminally differentiated functional human 
oligodendrocytes and astrocytes will be generated for use in in vivo studies to develop treatment 
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